Tamoxifen in advanced breast cancer: experience of the SAKK (Schweizerische Arbeitsgruppe für Klinische Krebsforschung--Swiss Cooperative Oncology Group).
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012075:Remission, Spontaneous; D013629:Tamoxifen / Q000008:administration & dosage* / Q000009:adverse effects
D000970:Antineoplastic Agents; D004967:Estrogens; D013629:Tamoxifen